These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 9297348)
21. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Jones SM; Feldmann H; Ströher U; Geisbert JB; Fernando L; Grolla A; Klenk HD; Sullivan NJ; Volchkov VE; Fritz EA; Daddario KM; Hensley LE; Jahrling PB; Geisbert TW Nat Med; 2005 Jul; 11(7):786-90. PubMed ID: 15937495 [TBL] [Abstract][Full Text] [Related]
22. [Recent Advances in Vaccines and Drugs Against the Ebola Virus]. Zhu X; Yao C; Wei Y; Kou Z; Hu K Bing Du Xue Bao; 2015 May; 31(3):287-92. PubMed ID: 26470536 [TBL] [Abstract][Full Text] [Related]
23. Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine. Zhou Y; Sullivan NJ Curr Opin Immunol; 2015 Aug; 35():131-6. PubMed ID: 26247875 [TBL] [Abstract][Full Text] [Related]
24. Towards a vaccine against Ebola virus. Geisbert TW; Jahrling PB Expert Rev Vaccines; 2003 Dec; 2(6):777-89. PubMed ID: 14711361 [TBL] [Abstract][Full Text] [Related]
25. [Effect of inactivated Ebola virus on colony forming activity of human hematopoietic stem cells]. Chepurnov AA; Tiunnikov GI; Chernukhin IV Vopr Virusol; 1997; 42(2):91-2. PubMed ID: 9182409 [TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of inactivated vaccines prepared with parainfluenza viruses type 1 and type 3, administered experimentally by nasal or oral route. Petrescu AL; Petica M; Bârnaure F; Athanasiu P Rom J Virol; 1998; 49(1-4):97-115. PubMed ID: 10892431 [TBL] [Abstract][Full Text] [Related]
34. [Developing methods of specific heterologic immunoglobulins preparation for urgent prevention of Ebola fever and study of their properties]. Cherpunov AA; Kudoiarova-Zubavichene NM; Dedkova LM; Sergeev NN; Netesov SV Vestn Ross Akad Med Nauk; 1998; (4):24-9. PubMed ID: 9633237 [TBL] [Abstract][Full Text] [Related]
35. Experimental vaccine protects monkeys against Ebola virus. Gottlieb S Bull World Health Organ; 2001; 79(1):79. PubMed ID: 11217674 [No Abstract] [Full Text] [Related]
36. Virology. New vaccine and treatment excite Ebola researchers. Enserink M Science; 2003 Nov; 302(5648):1141-2. PubMed ID: 14615510 [No Abstract] [Full Text] [Related]
37. Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins. Wilson JA; Bray M; Bakken R; Hart MK Virology; 2001 Aug; 286(2):384-90. PubMed ID: 11485406 [TBL] [Abstract][Full Text] [Related]